首页 > 最新文献

International heart journal最新文献

英文 中文
Torsade de Pointes Caused by a Compound Licorice Tablet 复方甘草片引起的心搏过速
IF 1.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-13 DOI: 10.1536/ihj.23-609
Yichao Zhang, Jing Yang, Junmin Xie

The clinical manifestations of licorice-induced pseudoaldosteronism include muscle weakness, periodic paralysis, hypokalemia, and hypertension. Excessive licorice consumption can lead to adverse reactions affecting multiple systems, including the endocrine, cardiovascular, nervous, digestive, and immune systems. Although licorice is a frequently used Chinese herbal medicine, life-threatening adverse reactions have been reported among its users. This article presents a case of severe hypokalemia, torsade de pointes, severe hypertension, and exacerbation of manic symptoms resulting from an overdose of compound licorice tablets. This study aimed to enhance the understanding of the causes of hypokalemia and raise awareness on the potentially fatal adverse reactions associated with licorice drugs.

甘草引起的假性醛固酮增多症的临床表现包括肌无力、周期性麻痹、低钾血症和高血压。过量服用甘草会导致影响多个系统的不良反应,包括内分泌、心血管、神经、消化和免疫系统。虽然甘草是一种常用的中药材,但在其使用者中也有出现危及生命的不良反应的报道。本文介绍了一例因过量服用复方甘草片而导致严重低钾血症、心搏骤停、严重高血压和躁狂症状加重的病例。本研究旨在加深对低钾血症病因的了解,并提高人们对甘草类药物潜在致命不良反应的认识。
{"title":"Torsade de Pointes Caused by a Compound Licorice Tablet","authors":"Yichao Zhang, Jing Yang, Junmin Xie","doi":"10.1536/ihj.23-609","DOIUrl":"https://doi.org/10.1536/ihj.23-609","url":null,"abstract":"</p><p>The clinical manifestations of licorice-induced pseudoaldosteronism include muscle weakness, periodic paralysis, hypokalemia, and hypertension. Excessive licorice consumption can lead to adverse reactions affecting multiple systems, including the endocrine, cardiovascular, nervous, digestive, and immune systems. Although licorice is a frequently used Chinese herbal medicine, life-threatening adverse reactions have been reported among its users. This article presents a case of severe hypokalemia, torsade de pointes, severe hypertension, and exacerbation of manic symptoms resulting from an overdose of compound licorice tablets. This study aimed to enhance the understanding of the causes of hypokalemia and raise awareness on the potentially fatal adverse reactions associated with licorice drugs.</p>\u0000<p></p>","PeriodicalId":13711,"journal":{"name":"International heart journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141613131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Significance and Potential Mechanism of Circ_00008842 in Acute Myocardial Infarction Circ_00008842 在急性心肌梗死中的临床意义和潜在机制
IF 1.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-13 DOI: 10.1536/ihj.24-009
Li Zhang, Ming Wang, Ran Liao, Qing Han

This study aimed to evaluate the clinical value of circ_0008842 in acute myocardial infarction (AMI) and explore the potential mechanisms.

GSE149051 and GSE160717 datasets analyze common differentially expressed circRNAs (coDEcircRNA) in AMI. RT-qPCR analysis of circ_0008842 mRNA levels in patients with AMI. ROC curve assesses the diagnostic value of circ_0008842 in AMI. A cell model of AMI was constructed by hypoxia-reoxygenation (H/R) -induced H9c2. Cell viability and apoptosis were examined by CCK-8 and flow cytometry. Enzyme-linked immunosorbent assay was used to explore myocardial injury markers CK-MB and cTnI secretion. Dual luciferase reporter assays validate circ_0008842 binding to miRNA. PPI network and gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment reveal potential functions and pathways of targets from the miRNA in AMI.

circ_0008842 is recognized as coDEcircRNA in AMI-related databases. circ_0008842 was greatly lower and miR-574-5p was significantly higher in patients with AMI than in healthy individuals. miR-574-5p is a target of circ_0008842. The sensitivity and specificity of circ_0008842 for diagnosing patients with AMI were 87.40% and 83.50%, respectively. Overexpression of circ_0008842 inhibited H/R induced apoptosis, increased cell viability, and decreased CK-MB and cTnI levels, which were partially abrogated by overexpression of miR-574-5p. Calmodulin-like protein 4 (CALML4) was the most connected hub gene in the PPI network of miR-574-5p predicted target genes.

circ_0008842 is a diagnostic biomarker for AMI and participates in myocardial injury in AMI by regulating miR-574-5p. Our study provides new insights into the diagnosis for AMI.

这项研究旨在评估circ_0008842在急性心肌梗死(AMI)中的临床价值,并探索其潜在机制。GSE149051和GSE160717数据集分析了AMI中常见的差异表达circRNA(coDEcircRNA)。对 AMI 患者中 circ_0008842 mRNA 水平的 RT-qPCR 分析。ROC 曲线评估了 circ_0008842 在 AMI 中的诊断价值。通过缺氧-复氧(H/R)诱导的 H9c2 构建了 AMI 的细胞模型。通过 CCK-8 和流式细胞术检测细胞活力和凋亡。酶联免疫吸附试验用于检测心肌损伤标志物 CK-MB 和 cTnI 的分泌。双荧光素酶报告实验验证了 circ_0008842 与 miRNA 的结合。PPI网络和基因本体论以及京都基因和基因组百科全书的通路富集揭示了miRNA在AMI中的潜在功能和靶标通路,circ_0008842在AMI相关数据库中被认定为coDEcircRNA,Circ_0008842在AMI患者中的含量大大低于健康人,而miR-574-5p则明显高于健康人。circ_0008842 对诊断 AMI 患者的敏感性和特异性分别为 87.40% 和 83.50%。过表达circ_0008842可抑制H/R诱导的细胞凋亡,提高细胞活力,降低CK-MB和cTnI水平,而过表达miR-574-5p可部分缓解这些作用。在miR-574-5p预测靶基因的PPI网络中,钙调蛋白样蛋白4(CALML4)是连接最紧密的枢纽基因。circ_0008842是AMI的诊断生物标志物,通过调控miR-574-5p参与AMI的心肌损伤。我们的研究为AMI的诊断提供了新的见解。
{"title":"Clinical Significance and Potential Mechanism of Circ_00008842 in Acute Myocardial Infarction","authors":"Li Zhang, Ming Wang, Ran Liao, Qing Han","doi":"10.1536/ihj.24-009","DOIUrl":"https://doi.org/10.1536/ihj.24-009","url":null,"abstract":"</p><p>This study aimed to evaluate the clinical value of circ_0008842 in acute myocardial infarction (AMI) and explore the potential mechanisms.</p><p>GSE149051 and GSE160717 datasets analyze common differentially expressed circRNAs (coDEcircRNA) in AMI. RT-qPCR analysis of circ_0008842 mRNA levels in patients with AMI. ROC curve assesses the diagnostic value of circ_0008842 in AMI. A cell model of AMI was constructed by hypoxia-reoxygenation (H/R) -induced H9c2. Cell viability and apoptosis were examined by CCK-8 and flow cytometry. Enzyme-linked immunosorbent assay was used to explore myocardial injury markers CK-MB and cTnI secretion. Dual luciferase reporter assays validate circ_0008842 binding to miRNA. PPI network and gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment reveal potential functions and pathways of targets from the miRNA in AMI.</p><p>circ_0008842 is recognized as coDEcircRNA in AMI-related databases. circ_0008842 was greatly lower and miR-574-5p was significantly higher in patients with AMI than in healthy individuals. miR-574-5p is a target of circ_0008842. The sensitivity and specificity of circ_0008842 for diagnosing patients with AMI were 87.40% and 83.50%, respectively. Overexpression of circ_0008842 inhibited H/R induced apoptosis, increased cell viability, and decreased CK-MB and cTnI levels, which were partially abrogated by overexpression of miR-574-5p. Calmodulin-like protein 4 (CALML4) was the most connected hub gene in the PPI network of miR-574-5p predicted target genes.</p><p>circ_0008842 is a diagnostic biomarker for AMI and participates in myocardial injury in AMI by regulating miR-574-5p. Our study provides new insights into the diagnosis for AMI.</p>\u0000<p></p>","PeriodicalId":13711,"journal":{"name":"International heart journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141613133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Prognostic Value of Advanced Lung Cancer Inflammation Index in Elderly Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention 接受经皮冠状动脉介入治疗的急性冠状动脉综合征老年患者的晚期肺癌炎症指数的预后价值
IF 1.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-13 DOI: 10.1536/ihj.24-046
Guoying Zhao, Wenbin Tang, Chao Yang, Xiao Liu, Jinyu Huang

This study aimed to investigate the predictive value of advanced lung cancer inflammation index (ALI) for major adverse cardiovascular events (MACEs) in elderly patients with acute coronary syndrome (ACS).

A total of 586 ACS patients undergoing percutaneous coronary intervention (PCI) over 65 years old between January 2017 and December 2018 were retrospectively collected. The patients were divided into two groups by the optimal cutoff value of ALI. Spearman rank correlation coefficient was used to evaluate the correlation between ALI and the Global Registry of Acute Coronary Events (GRACE). Time-dependent receiver operating characteristic (ROC) curves, Cox survival analysis, and Kaplan Meier curves were used to assess the predictive value of ALI for MACEs.

Spearman's nonparametric test revealed a moderate correlation between ALI and the GRACE (r: −0.417, P < 0.001). Time-dependent ROC curves showed that the area under the curve for ALI was 0.751 (95% CI, 0.699-0.798) in predicting MACEs, higher than Geriatric Nutritional Risk Index (0.531, 95% CI 0.435-0.627) and Prognostic Nutritional Index (0.590, 95% CI 0.505 - 0.676), and for combined diagnostic models (ALI + GRACE) was 0.913, (95% CI 0.875 - 0.942, P < 0.001). Multivariate Cox analysis demonstrated that ALI (HR: 0.974, 95% CI: 0.952-0.996, P = 0.017) was an independent risk factor for MACEs. Kaplan Meier survival analysis showed that the cumulative incidence of MACEs was significantly higher in elderly ACS patients with lower ALI (log-rank test, P < 0.001).

ALI could be a nutrition-inflammation indicator with independent predictive value for long-term MACEs of elderly ACS patients after PCI.

这项研究旨在探讨晚期肺癌炎症指数(ALI)对老年急性冠状动脉综合征(ACS)患者主要不良心血管事件(MACE)的预测价值。研究人员回顾性收集了2017年1月至2018年12月期间接受经皮冠状动脉介入治疗(PCI)的65岁以上ACS患者共586例。按照ALI的最佳临界值将患者分为两组。斯皮尔曼秩相关系数用于评估ALI与全球急性冠脉事件登记(GRACE)之间的相关性。Spearman非参数检验显示,ALI与GRACE之间存在中度相关性(r:-0.417,P <0.001)。时间依赖性 ROC 曲线显示,ALI 预测 MACE 的曲线下面积为 0.751(95% CI,0.699-0.798),高于老年营养风险指数(0.531,95% CI 0.435-0.627)和预后营养指数(0.590,95% CI 0.505 - 0.676),联合诊断模型(ALI + GRACE)为 0.913,(95% CI 0.875 - 0.942,P <0.001)。多变量 Cox 分析显示,ALI(HR:0.974,95% CI:0.952-0.996,P = 0.017)是 MACEs 的独立危险因素。Kaplan Meier生存分析显示,ALI较低的老年ACS患者的MACE累积发生率明显更高(对数秩检验,P < 0.001)。
{"title":"The Prognostic Value of Advanced Lung Cancer Inflammation Index in Elderly Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention","authors":"Guoying Zhao, Wenbin Tang, Chao Yang, Xiao Liu, Jinyu Huang","doi":"10.1536/ihj.24-046","DOIUrl":"https://doi.org/10.1536/ihj.24-046","url":null,"abstract":"</p><p>This study aimed to investigate the predictive value of advanced lung cancer inflammation index (ALI) for major adverse cardiovascular events (MACEs) in elderly patients with acute coronary syndrome (ACS).</p><p>A total of 586 ACS patients undergoing percutaneous coronary intervention (PCI) over 65 years old between January 2017 and December 2018 were retrospectively collected. The patients were divided into two groups by the optimal cutoff value of ALI. Spearman rank correlation coefficient was used to evaluate the correlation between ALI and the Global Registry of Acute Coronary Events (GRACE). Time-dependent receiver operating characteristic (ROC) curves, Cox survival analysis, and Kaplan Meier curves were used to assess the predictive value of ALI for MACEs.</p><p>Spearman's nonparametric test revealed a moderate correlation between ALI and the GRACE (r: −0.417, <i>P</i> &lt; 0.001). Time-dependent ROC curves showed that the area under the curve for ALI was 0.751 (95% CI, 0.699-0.798) in predicting MACEs, higher than Geriatric Nutritional Risk Index (0.531, 95% CI 0.435-0.627) and Prognostic Nutritional Index (0.590, 95% CI 0.505 - 0.676), and for combined diagnostic models (ALI + GRACE) was 0.913, (95% CI 0.875 - 0.942, <i>P</i> &lt; 0.001). Multivariate Cox analysis demonstrated that ALI (HR: 0.974, 95% CI: 0.952-0.996, <i>P</i> = 0.017) was an independent risk factor for MACEs. Kaplan Meier survival analysis showed that the cumulative incidence of MACEs was significantly higher in elderly ACS patients with lower ALI (log-rank test, <i>P</i> &lt; 0.001).</p><p>ALI could be a nutrition-inflammation indicator with independent predictive value for long-term MACEs of elderly ACS patients after PCI.</p>\u0000<p></p>","PeriodicalId":13711,"journal":{"name":"International heart journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141612961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Retrograde Percutaneous Coronary Intervention for Chronic Total Occlusion in a Patient with Dextrocardia 成功逆行经皮冠状动脉介入治疗右心室患者的慢性全闭塞
IF 1.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-13 DOI: 10.1536/ihj.23-622
Xin Zhong, Liang Xu, Junhua Sun, Hongzhi Dui, Yong Dong, Chenhai Xia, Yujie Zhao, Ming Yuan, Tao Hu

Dextrocardia is a very rare congenital malposition, and most cardiologists are not familiar with the radiographic angiograms of this condition. Here, we first report a case of dextrocardia with a chronic total occlusion (CTO) lesion undergoing retrograde percutaneous coronary intervention (PCI). Significant difficulties in lesion interpretation and device manipulation were encountered with the original angiograms. These challenges were not significantly improved until we adopted the double-inversion technique. The procedure was finally accomplished by using the kissing wire technique with a poor angle of attack. Retrograde CTO PCI for patients with dextrocardia is feasible with adequate techniques.

右心室突出是一种非常罕见的先天性错位,大多数心脏病专家对这种情况的血管造影并不熟悉。在此,我们首次报告了一例接受逆行经皮冠状动脉介入治疗(PCI)的伴有慢性全闭塞(CTO)病变的右心室缺血病例。最初的血管造影在病变解读和设备操作方面遇到了很大的困难。直到我们采用双倒置技术,这些难题才得到明显改善。最终,我们采用攻角较差的吻合导丝技术完成了手术。通过适当的技术,逆行 CTO PCI 治疗右心室患者是可行的。
{"title":"Successful Retrograde Percutaneous Coronary Intervention for Chronic Total Occlusion in a Patient with Dextrocardia","authors":"Xin Zhong, Liang Xu, Junhua Sun, Hongzhi Dui, Yong Dong, Chenhai Xia, Yujie Zhao, Ming Yuan, Tao Hu","doi":"10.1536/ihj.23-622","DOIUrl":"https://doi.org/10.1536/ihj.23-622","url":null,"abstract":"</p><p>Dextrocardia is a very rare congenital malposition, and most cardiologists are not familiar with the radiographic angiograms of this condition. Here, we first report a case of dextrocardia with a chronic total occlusion (CTO) lesion undergoing retrograde percutaneous coronary intervention (PCI). Significant difficulties in lesion interpretation and device manipulation were encountered with the original angiograms. These challenges were not significantly improved until we adopted the double-inversion technique. The procedure was finally accomplished by using the kissing wire technique with a poor angle of attack. Retrograde CTO PCI for patients with dextrocardia is feasible with adequate techniques.</p>\u0000<p></p>","PeriodicalId":13711,"journal":{"name":"International heart journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141614996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iron Deficiency in Pulmonary Hypertension Implications, Supplementation, and Future Directions 肺动脉高压缺铁的影响、补充和未来方向
IF 1.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-07-13 DOI: 10.1536/ihj.24-055
Arif Albulushi, Masoud Kashoub, Khalid Al-Saidi, Hatem Al-Farhan

Pulmonary hypertension (PH) is a complex cardiovascular condition that is characterized by elevated pulmonary arterial pressure, which leads to significant morbidity and mortality. Among the various factors that influence the pathophysiology and progression of PH, iron deficiency has become a critical, yet often overlooked, element. In this review, the prevalence, implications, and therapeutic potential of addressing iron deficiency in patients with PH are elucidated.

Iron deficiency, which is prevalent in a significant proportion of patients with PH, has been associated with worsened clinical outcomes, including diminished exercise capacity, impaired oxygen transport and utilization, and compromised right ventricular function. The pathophysiological linkages between iron deficiency and PH are multifaceted and involve alterations in oxygen sensing, endothelial function, and metabolic disturbances.

In this review, the evidence from recent clinical trials and studies that assess the impact of iron supplementation, both oral and intravenous, on PH outcomes is critically analyzed. Although some studies suggest improvements in exercise capacity and hemodynamic parameters following iron repletion, the responses appear variable and are not universally beneficial. This review highlights the complexities of iron metabolism in PH and the challenges in effectively diagnosing and treating iron deficiency in this patient population.

Furthermore, the potential mechanisms through which iron supplementation might influence pulmonary vascular and right ventricular function, emphasizing the need for personalized treatment approaches are discussed. In this review, the importance of recognizing iron deficiency in the management of patients with PH is highlighted, and further research is warranted to establish comprehensive, evidence-based guidelines for iron supplementation in this unique patient cohort. The ultimate goal of this review is to improve clinical outcomes and quality of life for patients suffering from this debilitating condition.

肺动脉高压(PH)是一种复杂的心血管疾病,其特点是肺动脉压力升高,会导致严重的发病率和死亡率。在影响 PH 病理生理学和进展的各种因素中,缺铁已成为一个关键因素,但却常常被忽视。在这篇综述中,将阐明 PH 患者缺铁的患病率、影响和治疗潜力。铁缺乏在相当一部分 PH 患者中普遍存在,与临床结果恶化有关,包括运动能力下降、氧运输和利用受损以及右心室功能受损。缺铁与 PH 之间的病理生理学联系是多方面的,涉及氧传感、内皮功能和代谢紊乱的改变。在本综述中,对近期临床试验和研究中的证据进行了批判性分析,这些试验和研究评估了口服和静脉补铁对 PH 预后的影响。尽管一些研究表明补铁后运动能力和血液动力学参数有所改善,但这些反应似乎各不相同,而且并非普遍有益。本综述强调了 PH 中铁代谢的复杂性,以及有效诊断和治疗这类患者缺铁所面临的挑战。此外,还讨论了补铁可能影响肺血管和右心室功能的潜在机制,强调了个性化治疗方法的必要性。本综述强调了在 PH 患者的治疗过程中识别铁缺乏症的重要性,并认为有必要开展进一步研究,为这一独特的患者群体制定全面、循证的补铁指南。本综述的最终目的是改善临床疗效,提高这一衰弱性疾病患者的生活质量。
{"title":"Iron Deficiency in Pulmonary Hypertension Implications, Supplementation, and Future Directions","authors":"Arif Albulushi, Masoud Kashoub, Khalid Al-Saidi, Hatem Al-Farhan","doi":"10.1536/ihj.24-055","DOIUrl":"https://doi.org/10.1536/ihj.24-055","url":null,"abstract":"</p><p>Pulmonary hypertension (PH) is a complex cardiovascular condition that is characterized by elevated pulmonary arterial pressure, which leads to significant morbidity and mortality. Among the various factors that influence the pathophysiology and progression of PH, iron deficiency has become a critical, yet often overlooked, element. In this review, the prevalence, implications, and therapeutic potential of addressing iron deficiency in patients with PH are elucidated.</p><p>Iron deficiency, which is prevalent in a significant proportion of patients with PH, has been associated with worsened clinical outcomes, including diminished exercise capacity, impaired oxygen transport and utilization, and compromised right ventricular function. The pathophysiological linkages between iron deficiency and PH are multifaceted and involve alterations in oxygen sensing, endothelial function, and metabolic disturbances.</p><p>In this review, the evidence from recent clinical trials and studies that assess the impact of iron supplementation, both oral and intravenous, on PH outcomes is critically analyzed. Although some studies suggest improvements in exercise capacity and hemodynamic parameters following iron repletion, the responses appear variable and are not universally beneficial. This review highlights the complexities of iron metabolism in PH and the challenges in effectively diagnosing and treating iron deficiency in this patient population.</p><p>Furthermore, the potential mechanisms through which iron supplementation might influence pulmonary vascular and right ventricular function, emphasizing the need for personalized treatment approaches are discussed. In this review, the importance of recognizing iron deficiency in the management of patients with PH is highlighted, and further research is warranted to establish comprehensive, evidence-based guidelines for iron supplementation in this unique patient cohort. The ultimate goal of this review is to improve clinical outcomes and quality of life for patients suffering from this debilitating condition.</p>\u0000<p></p>","PeriodicalId":13711,"journal":{"name":"International heart journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141612963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MiR-411-5p Promotes Vascular Smooth Muscle Cell Phenotype Switch by Inhibiting Expression of Calmodulin Regulated Spectrin-Associated Protein-1 MiR-411-5p 通过抑制钙调蛋白调控谱联蛋白-1 的表达促进血管平滑肌细胞表型转换
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2024-05-31 DOI: 10.1536/ihj.23-590
Yong Qiao, Dong Wang, Gaoliang Yan, Zhanneng Yang, Chengchun Tang

When stimulated, vascular smooth muscle cells (VSMCs) change from a differentiated to a dedifferentiated phenotype. Dedifferentiated VSMCs have a key activity in cardiovascular diseases such as in-stent restenosis. MicroRNAs (miRNAs) have crucial functions in conversion of differentiated VSMCs to a dedifferentiated phenotype. We investigated the activity of miR-411-5p in the proliferation, migration, and phenotype switch of rat VSMCs.

Based on a microRNA array assay, miR-411-5p expression was found to be significantly increased in cultured VSMCs stimulated by platelet-derived growth factor-BB (PDGF-BB). A CCK-8 assay, transwell assay, and scratch test were performed to measure the effect of miR-411-5p on the proliferation and migration of PDGF-BB-treated VSMCs. MiR-411-5p promoted expression of dedifferentiated phenotype markers such as osteopontin and tropomyosin 4 in PDGF-BB-treated VSMCs. Using mimics and inhibitors, we identified the target of miR-411-5p in PDGF-BB-treated VSMCs and found that calmodulin-regulated spectrin-associated protein-1 (CAMSAP1) was involved in the phenotypic switch mediated by PDGF-BB.

By inhibiting expression of CAMSAP1, miR-411-5p enhanced the proliferation, migration, and phenotype switch of VSMCs.

Blockade of miR-411-5p interaction with CAMSAP1 is a promising approach to treat in-stent restenosis.

当受到刺激时,血管平滑肌细胞(VSMC)会从分化表型转变为去分化表型。脱分化的血管平滑肌细胞在支架内再狭窄等心血管疾病中具有关键活性。微小 RNA(miRNA)在分化型 VSMC 转换为去分化型表型的过程中具有关键作用。我们研究了 miR-411-5p 在大鼠血管内皮细胞增殖、迁移和表型转换中的活性。基于 microRNA 阵列检测,我们发现在血小板衍生生长因子-BB(PDGF-BB)刺激下培养的血管内皮细胞中,miR-411-5p 的表达显著增加。研究人员采用 CCK-8 试验、Transwell 试验和划痕试验来测定 miR-411-5p 对经 PDGF-BB 处理的 VSMC 增殖和迁移的影响。MiR-411-5p 促进了 PDGF-BB 处理的 VSMCs 中骨桥蛋白和肌球蛋白 4 等去分化表型标志物的表达。利用模拟物和抑制剂,我们确定了 miR-411-5p 在 PDGF-BB 处理的 VSMCs 中的靶点,并发现钙调蛋白调节的谱蛋白相关蛋白-1(CAMSAP1)参与了 PDGF-BB 介导的表型转换。通过抑制 CAMSAP1 的表达,miR-411-5p 增强了 VSMC 的增殖、迁移和表型转换。
{"title":"MiR-411-5p Promotes Vascular Smooth Muscle Cell Phenotype Switch by Inhibiting Expression of Calmodulin Regulated Spectrin-Associated Protein-1","authors":"Yong Qiao, Dong Wang, Gaoliang Yan, Zhanneng Yang, Chengchun Tang","doi":"10.1536/ihj.23-590","DOIUrl":"https://doi.org/10.1536/ihj.23-590","url":null,"abstract":"</p><p>When stimulated, vascular smooth muscle cells (VSMCs) change from a differentiated to a dedifferentiated phenotype. Dedifferentiated VSMCs have a key activity in cardiovascular diseases such as in-stent restenosis. MicroRNAs (miRNAs) have crucial functions in conversion of differentiated VSMCs to a dedifferentiated phenotype. We investigated the activity of miR-411-5p in the proliferation, migration, and phenotype switch of rat VSMCs.</p><p>Based on a microRNA array assay, miR-411-5p expression was found to be significantly increased in cultured VSMCs stimulated by platelet-derived growth factor-BB (PDGF-BB). A CCK-8 assay, transwell assay, and scratch test were performed to measure the effect of miR-411-5p on the proliferation and migration of PDGF-BB-treated VSMCs. MiR-411-5p promoted expression of dedifferentiated phenotype markers such as osteopontin and tropomyosin 4 in PDGF-BB-treated VSMCs. Using mimics and inhibitors, we identified the target of miR-411-5p in PDGF-BB-treated VSMCs and found that calmodulin-regulated spectrin-associated protein-1 (CAMSAP1) was involved in the phenotypic switch mediated by PDGF-BB.</p><p>By inhibiting expression of CAMSAP1, miR-411-5p enhanced the proliferation, migration, and phenotype switch of VSMCs.</p><p>Blockade of miR-411-5p interaction with CAMSAP1 is a promising approach to treat in-stent restenosis.</p>\u0000<p></p>","PeriodicalId":13711,"journal":{"name":"International heart journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141198165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bidirectional Association Among the Type of Atrial Fibrillation, Sleep-Disordered Breathing Severity, Heart Failure Progression, and Left Atrial Enlargement, in Patients with Atrial Fibrillation 心房颤动患者的心房颤动类型、睡眠呼吸障碍严重程度、心力衰竭进展和左心房扩大之间的双向关系
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2024-05-31 DOI: 10.1536/ihj.23-493
Togo Sakai, Masao Takemoto, Yoshibumi Antoku, Takahiro Mito, Shota Ikeda, Tomohiro Takiguchi, Eiji Nyuta, Tokushi Koga, Takuya Tsuchihashi

This study aimed to clarify (1) the association among the atrial fibrillation (AF) type, sleep-disordered breathing (SDB), heart failure (HF), and left atrial (LA) enlargement, (2) the independent predictors of LA enlargement, and (3) the effects of ablation on those conditions in patients with AF. The study's endpoint was LA enlargement (LA volume index [LAVI] ≥ 78 mL/m2).

Of 423 patients with nonvalvular AF, 236 were enrolled. We evaluated the role of the clinical parameters such as the AF type, SDB severity, and HF in LA enlargement. Among them, 141 patients exhibiting a 3% oxygen desaturation index (ODI) of ≥ 10 events/hour underwent polysomnography to evaluate the SDB severity measured by the apnea-hypopnea index (AHI). The LA enlargement and HF were characterized by the LA diameter/LAVI, an increase in the B-type natriuretic peptide level, and a lower left ventricular ejection fraction.

This study showed that non-paroxysmal AF (NPAF) rather than paroxysmal AF (PAF), the SDB severity, LA enlargement, and HF progression had bidirectional associations and exacerbated each other, which generated a vicious cycle that contributed to the LA enlargement. NPAF (OR = 4.55, P < 0.001), an AHI of ≥ 25.10 events/hour (OR = 1.55, P = 0.003), and a 3% ODI of ≥ 15.43 events/hour (OR = 1.52, P = 0.003) were independent predictors of an acceleration of the LA enlargement. AF ablation improved the HF and LA enlargement.

To break this vicious cycle, AF ablation may be the basis for suppressing the LA enlargement and HF progression subsequently eliminating the substrates for AF and SDB in patients with AF.

本研究旨在阐明:(1) 心房颤动(AF)类型、睡眠呼吸障碍(SDB)、心力衰竭(HF)和左心房(LA)扩大之间的关联;(2) LA 扩大的独立预测因素;(3) 心房颤动患者消融术对这些情况的影响。该研究的终点是 LA 扩大(LA 容积指数 [LAVI] ≥ 78 mL/m2)。在 423 名非瓣膜性房颤患者中,有 236 人被纳入研究。我们评估了房颤类型、SDB 严重程度和 HF 等临床参数在 LA 扩大中的作用。其中,141 名患者的 3% 氧饱和度指数(ODI)≥ 10 次/小时,他们接受了多导睡眠图检查,以评估以呼吸暂停-低通气指数(AHI)测量的 SDB 严重程度。该研究表明,非阵发性房颤(NPAF)而非阵发性房颤(PAF)、SDB严重程度、LA扩大和HF进展之间存在双向关联,并相互加剧,从而形成恶性循环,导致LA扩大。NPAF(OR = 4.55,P < 0.001)、AHI ≥ 25.10 次/小时(OR = 1.55,P = 0.003)和 3% ODI ≥ 15.43 次/小时(OR = 1.52,P = 0.003)是加速 LA 扩大的独立预测因素。为了打破这一恶性循环,房颤消融可能是抑制 LA 扩大和 HF 进展的基础,从而消除房颤患者房颤和 SDB 的基质。
{"title":"Bidirectional Association Among the Type of Atrial Fibrillation, Sleep-Disordered Breathing Severity, Heart Failure Progression, and Left Atrial Enlargement, in Patients with Atrial Fibrillation","authors":"Togo Sakai, Masao Takemoto, Yoshibumi Antoku, Takahiro Mito, Shota Ikeda, Tomohiro Takiguchi, Eiji Nyuta, Tokushi Koga, Takuya Tsuchihashi","doi":"10.1536/ihj.23-493","DOIUrl":"https://doi.org/10.1536/ihj.23-493","url":null,"abstract":"</p><p>This study aimed to clarify (1) the association among the atrial fibrillation (AF) type, sleep-disordered breathing (SDB), heart failure (HF), and left atrial (LA) enlargement, (2) the independent predictors of LA enlargement, and (3) the effects of ablation on those conditions in patients with AF. The study's endpoint was LA enlargement (LA volume index [LAVI] ≥ 78 mL/m<sup>2</sup>).</p><p>Of 423 patients with nonvalvular AF, 236 were enrolled. We evaluated the role of the clinical parameters such as the AF type, SDB severity, and HF in LA enlargement. Among them, 141 patients exhibiting a 3% oxygen desaturation index (ODI) of ≥ 10 events/hour underwent polysomnography to evaluate the SDB severity measured by the apnea-hypopnea index (AHI). The LA enlargement and HF were characterized by the LA diameter/LAVI, an increase in the B-type natriuretic peptide level, and a lower left ventricular ejection fraction.</p><p>This study showed that non-paroxysmal AF (NPAF) rather than paroxysmal AF (PAF), the SDB severity, LA enlargement, and HF progression had bidirectional associations and exacerbated each other, which generated a vicious cycle that contributed to the LA enlargement. NPAF (OR = 4.55, <i>P</i> &lt; 0.001), an AHI of ≥ 25.10 events/hour (OR = 1.55, <i>P</i> = 0.003), and a 3% ODI of ≥ 15.43 events/hour (OR = 1.52, <i>P</i> = 0.003) were independent predictors of an acceleration of the LA enlargement. AF ablation improved the HF and LA enlargement.</p><p>To break this vicious cycle, AF ablation may be the basis for suppressing the LA enlargement and HF progression subsequently eliminating the substrates for AF and SDB in patients with AF.</p>\u0000<p></p>","PeriodicalId":13711,"journal":{"name":"International heart journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141198135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hydrogen Sulfide Promotes Postnatal Cardiomyocyte Proliferation by Upregulating SIRT1 Signaling Pathway 硫化氢通过上调 SIRT1 信号通路促进出生后心肌细胞增殖
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2024-05-31 DOI: 10.1536/ihj.23-370
Lu Gan, Peng Cheng, Jieyun Wu, Qiyong Li, Jigang Pan, Yan Ding, Xiufeng Gao, Li Chen

Hydrogen sulfide (H2S) has been identified as a novel gasotransmitter and a substantial antioxidant that can activate various cellular targets to regulate physiological and pathological processes in mammals. However, under physiological conditions, it remains unclear whether it is involved in regulating cardiomyocyte (CM) proliferation during postnatal development in mice. This study mainly aimed to evaluate the role of H2S in postnatal CM proliferation and its regulating molecular mechanisms. We found that sodium hydrosulfide (NaHS, the most widely used H2S donor, 50-200 μM) increased neonatal mouse primary CM proliferation in a dose-dependent manner in vitro. Consistently, exogenous administration of H2S also promoted CM proliferation and increased the total number of CMs at postnatal 7 and 14 days in vivo. Moreover, we observed that the protein expression of SIRT1 was significantly upregulated after NaHS treatment. Inhibition of SIRT1 with EX-527 or si-SIRT1 decreased CM proliferation, while enhancement of the activation of SIRT1 with SRT1720 promoted CM proliferation. Meanwhile, pharmacological and genetic blocking of SIRT1 repressed the effect of NaHS on CM proliferation. Taken together, these results reveal that H2S plays a promotional role in proliferation of CMs in vivo and in vitro and SIRT1 is required for H2S-mediated CM proliferation, which indicates that H2S may be a potential modulator for heart development in postnatal time window.

硫化氢(H2S)已被确认为一种新型的气体递质和一种重要的抗氧化剂,可激活各种细胞靶点,调节哺乳动物的生理和病理过程。然而,在生理条件下,它是否参与调节小鼠出生后发育过程中心肌细胞(CM)的增殖仍不清楚。本研究的主要目的是评估 H2S 在小鼠出生后 CM 增殖中的作用及其调控分子机制。我们发现,硫氢化钠(NaHS,最广泛使用的 H2S 供体,50-200 μM)能以剂量依赖的方式在体外增加新生小鼠原代 CM 的增殖。同样,外源性给予 H2S 也能促进 CM 增殖,并增加出生后 7 天和 14 天体内 CM 的总数。此外,我们还观察到 NaHS 处理后 SIRT1 蛋白表达明显上调。用 EX-527 或 si-SIRT1 抑制 SIRT1 会减少 CM 的增殖,而用 SRT1720 增强 SIRT1 的活化会促进 CM 的增殖。同时,药物和基因阻断 SIRT1 可抑制 NaHS 对 CM 增殖的影响。综上所述,这些结果揭示了H2S在体内和体外对CM的增殖起促进作用,而SIRT1是H2S介导的CM增殖所必需的,这表明H2S可能是出生后时间窗心脏发育的潜在调节因子。
{"title":"Hydrogen Sulfide Promotes Postnatal Cardiomyocyte Proliferation by Upregulating SIRT1 Signaling Pathway","authors":"Lu Gan, Peng Cheng, Jieyun Wu, Qiyong Li, Jigang Pan, Yan Ding, Xiufeng Gao, Li Chen","doi":"10.1536/ihj.23-370","DOIUrl":"https://doi.org/10.1536/ihj.23-370","url":null,"abstract":"</p><p>Hydrogen sulfide (H<sub>2</sub>S) has been identified as a novel gasotransmitter and a substantial antioxidant that can activate various cellular targets to regulate physiological and pathological processes in mammals. However, under physiological conditions, it remains unclear whether it is involved in regulating cardiomyocyte (CM) proliferation during postnatal development in mice. This study mainly aimed to evaluate the role of H<sub>2</sub>S in postnatal CM proliferation and its regulating molecular mechanisms. We found that sodium hydrosulfide (NaHS, the most widely used H<sub>2</sub>S donor, 50-200 μM) increased neonatal mouse primary CM proliferation in a dose-dependent manner<i> in vitro</i>. Consistently, exogenous administration of H<sub>2</sub>S also promoted CM proliferation and increased the total number of CMs at postnatal 7 and 14 days <i>in vivo</i>. Moreover, we observed that the protein expression of SIRT1 was significantly upregulated after NaHS treatment. Inhibition of SIRT1 with EX-527 or si-SIRT1 decreased CM proliferation, while enhancement of the activation of SIRT1 with SRT1720 promoted CM proliferation. Meanwhile, pharmacological and genetic blocking of SIRT1 repressed the effect of NaHS on CM proliferation. Taken together, these results reveal that H<sub>2</sub>S plays a promotional role in proliferation of CMs <i>in vivo</i> and <i>in vitro</i> and SIRT1 is required for H<sub>2</sub>S-mediated CM proliferation, which indicates that H<sub>2</sub>S may be a potential modulator for heart development in postnatal time window.</p>\u0000<p></p>","PeriodicalId":13711,"journal":{"name":"International heart journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141187982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Late Kidney Injury After Admission to Intensive Care Unit for Acute Heart Failure 急性心力衰竭患者入住重症监护室后的晚期肾损伤
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2024-05-31 DOI: 10.1536/ihj.23-603
Masaki Morooka, Akihiro Shirakabe, Hirotake Okazaki, Masato Matsushita, Shota Shigihara, Suguru Nishigoori, Tomofumi Sawatani, Kenichi Tani, Kazutaka Kiuchi, Shohei Kawakami, Yu Michiura, Shogo Kamitani, Nobuaki Kobayashi, Kuniya Asai

Late kidney injury (LKI) in patients with acute heart failure (AHF) requiring intensive care is poorly understood.

We analyzed 821 patients with AHF who required intensive care. We defined LKI based on the ratio of the creatinine level 1 year after admission for AHF to the baseline creatinine level. The patients were categorized into 4 groups based on this ratio: no-LKI (< 1.5, n = 509), Class R (risk; ≥ 1.5, n = 214), Class I (injury; ≥ 2.0, n = 78), and Class F (failure; ≥ 3.0, n = 20). Median follow-up after admission for AHF was 385 (346-426) days. Multivariate logistic regression analysis revealed that acute kidney injury (AKI) during hospitalization (Class R, odds ratio [OR]: 1.710, 95% confidence interval [CI]: 1.138-2.571, P = 0.010; Class I, OR: 6.744, 95% CI: 3.739-12.163, P < 0.001; and Class F, OR: 9.259, 95% CI: 4.078-18.400, P < 0.001) was independently associated with LKI. Multivariate Cox regression analysis showed that LKI was an independent predictor of 3-year all-cause death after final follow-up (hazard ratio: 1.545, 95% CI: 1.099-2.172, P = 0.012). The rate of all-cause death was significantly lower in the no-AKI/no-LKI group than in the no-AKI/LKI group (P = 0.048) and in the AKI/no-LKI group than in the AKI/LKI group (P = 0.017).

The incidence of LKI was influenced by the presence of AKI during hospitalization, and was associated with poor outcomes within 3 years of final follow-up. In the absence of LKI, AKI during hospitalization for AHF was not associated with a poor outcome.

我们对 821 名需要接受重症监护的急性心力衰竭(AHF)患者进行了分析。我们根据急性心力衰竭患者入院一年后的肌酐水平与基线肌酐水平之比来定义晚期肾损伤。根据这一比率将患者分为 4 组:无 LKI(< 1.5,n = 509)、R 级(风险;≥ 1.5,n = 214)、I 级(损伤;≥ 2.0,n = 78)和 F 级(失败;≥ 3.0,n = 20)。AHF入院后的中位随访天数为385(346-426)天。多变量逻辑回归分析显示,住院期间的急性肾损伤(AKI)(R 级,几率比 [OR]:1.710,95% 置信区间 [CI]:1.138-2.571,P = 0.010;I 级,OR:6.744,95% CI:3.739-12.163,P <;0.001;F 级,OR:9.259,95% CI:4.078-18.400,P <;0.001)与 LKI 独立相关。多变量 Cox 回归分析显示,LKI 是最终随访后 3 年全因死亡的独立预测因素(危险比:1.545,95% CI:1.099-2.172,P = 0.012)。无AKI/无LKI组的全因死亡率明显低于无AKI/LKI组(P = 0.048),AKI/无LKI组的全因死亡率明显低于AKI/LKI组(P = 0.017)。在没有LKI的情况下,AHF住院期间的AKI与不良预后无关。
{"title":"Late Kidney Injury After Admission to Intensive Care Unit for Acute Heart Failure","authors":"Masaki Morooka, Akihiro Shirakabe, Hirotake Okazaki, Masato Matsushita, Shota Shigihara, Suguru Nishigoori, Tomofumi Sawatani, Kenichi Tani, Kazutaka Kiuchi, Shohei Kawakami, Yu Michiura, Shogo Kamitani, Nobuaki Kobayashi, Kuniya Asai","doi":"10.1536/ihj.23-603","DOIUrl":"https://doi.org/10.1536/ihj.23-603","url":null,"abstract":"</p><p>Late kidney injury (LKI) in patients with acute heart failure (AHF) requiring intensive care is poorly understood.</p><p>We analyzed 821 patients with AHF who required intensive care. We defined LKI based on the ratio of the creatinine level 1 year after admission for AHF to the baseline creatinine level. The patients were categorized into 4 groups based on this ratio: no-LKI (&lt; 1.5, <i>n</i> = 509), Class R (risk; ≥ 1.5, <i>n</i> = 214), Class I (injury; ≥ 2.0, <i>n</i> = 78), and Class F (failure; ≥ 3.0, <i>n</i> = 20). Median follow-up after admission for AHF was 385 (346-426) days. Multivariate logistic regression analysis revealed that acute kidney injury (AKI) during hospitalization (Class R, odds ratio [OR]: 1.710, 95% confidence interval [CI]: 1.138-2.571, <i>P</i> = 0.010; Class I, OR: 6.744, 95% CI: 3.739-12.163, <i>P</i> &lt; 0.001; and Class F, OR: 9.259, 95% CI: 4.078-18.400, <i>P</i> &lt; 0.001) was independently associated with LKI. Multivariate Cox regression analysis showed that LKI was an independent predictor of 3-year all-cause death after final follow-up (hazard ratio: 1.545, 95% CI: 1.099-2.172, <i>P</i> = 0.012). The rate of all-cause death was significantly lower in the no-AKI/no-LKI group than in the no-AKI/LKI group (<i>P</i> = 0.048) and in the AKI/no-LKI group than in the AKI/LKI group (<i>P</i> = 0.017).</p><p>The incidence of LKI was influenced by the presence of AKI during hospitalization, and was associated with poor outcomes within 3 years of final follow-up. In the absence of LKI, AKI during hospitalization for AHF was not associated with a poor outcome.</p>\u0000<p></p>","PeriodicalId":13711,"journal":{"name":"International heart journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141187981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Oral Care on Endothelial Dysfunction in Patients with Acute Coronary Syndrome 口腔护理对急性冠状动脉综合征患者内皮功能障碍的影响
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2024-05-31 DOI: 10.1536/ihj.23-553
Shunichi Imamura, Masaaki Miyata, Masakazu Ogawa, Naoya Oketani, Shuichi Hamasaki, Narihiro Hirahara, Yuichi Ninomiya, Mitsuru Ohishi

Periodontitis is a common chronic infection and is associated with cardiovascular disease. This study evaluated whether basic oral care for periodontal disease could improve endothelial function in patients with acute coronary syndrome (ACS).

This study enrolled 54 patients with acute coronary syndrome admitted to Kagoshima City Hospital and who had undergone percutaneous coronary intervention. Flow-mediated endothelium-dependent dilatation (FMD) was measured before discharge (initial FMD) and at 8 months after percutaneous coronary intervention (follow-up FMD). The following periodontal characteristics were measured: periodontal pocket depth (PPD, mm), plaque control record (%), and bleeding on probing (%). All patients received basic oral care instructions from dentists. The oral health condition was generally poor in the participants and there were 24 patients (44.4%) who had severe PPD. Despite the intervention of basic oral care, the periodontal characteristics did not improve during the study period; initial FMD and follow-up FMD did not significantly differ (4.38 ± 2.74% versus 4.56 ± 2.51%, P = 0.562). However, the follow-up FMD was significantly lower in patients with severe PPD (≥ 6.0 mm, n = 24) than in patients without severe PPD (≤ 5.0 mm, n = 30) (FMD: 3.58 ± 1.91% versus 5.37 ± 2.67%, P = 0.007). FMD tended to be worse in patients with severe PPD than in patients without severe PPD (ΔFMD: -0.55 ± 2.12 versus 0.81 ± 2.77 %, P = 0.055). In conclusion, during the use of basic oral care, endothelial function improved in patients without severe PPD, while it worsened in patients with severe PPD.

牙周炎是一种常见的慢性感染,与心血管疾病有关。本研究评估了针对牙周病的基本口腔护理是否能改善急性冠状动脉综合征(ACS)患者的内皮功能。本研究招募了 54 名入住鹿儿岛市立医院并接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者。在出院前(初始 FMD)和经皮冠状动脉介入治疗后 8 个月(随访 FMD)测量了血流介导的内皮依赖性扩张(FMD)。还测量了以下牙周特征:牙周袋深度(PPD,毫米)、牙菌斑控制记录(%)和探诊出血(%)。所有患者都接受了牙医的基本口腔护理指导。参与者的口腔健康状况普遍较差,其中有 24 名患者(44.4%)的牙周袋深度严重超标。尽管进行了基本口腔护理干预,但牙周特征在研究期间并未得到改善;初始 FMD 和随访 FMD 没有显著差异(4.38 ± 2.74% 对 4.56 ± 2.51%,P = 0.562)。然而,重度 PPD 患者(≥ 6.0 mm,n = 24)的随访 FMD 明显低于非重度 PPD 患者(≤ 5.0 mm,n = 30)(FMD:3.58 ± 1.91% 对 5.37 ± 2.67%,P = 0.007)。重度 PPD 患者的 FMD 往往比无重度 PPD 患者差(ΔFMD:-0.55 ± 2.12 对 0.81 ± 2.77 %,P = 0.055)。总之,在使用基本口腔护理的过程中,未患严重口腔疾病的患者的内皮功能有所改善,而患严重口腔疾病的患者的内皮功能则有所恶化。
{"title":"Effect of Oral Care on Endothelial Dysfunction in Patients with Acute Coronary Syndrome","authors":"Shunichi Imamura, Masaaki Miyata, Masakazu Ogawa, Naoya Oketani, Shuichi Hamasaki, Narihiro Hirahara, Yuichi Ninomiya, Mitsuru Ohishi","doi":"10.1536/ihj.23-553","DOIUrl":"https://doi.org/10.1536/ihj.23-553","url":null,"abstract":"</p><p>Periodontitis is a common chronic infection and is associated with cardiovascular disease. This study evaluated whether basic oral care for periodontal disease could improve endothelial function in patients with acute coronary syndrome (ACS).</p><p>This study enrolled 54 patients with acute coronary syndrome admitted to Kagoshima City Hospital and who had undergone percutaneous coronary intervention. Flow-mediated endothelium-dependent dilatation (FMD) was measured before discharge (initial FMD) and at 8 months after percutaneous coronary intervention (follow-up FMD). The following periodontal characteristics were measured: periodontal pocket depth (PPD, mm), plaque control record (%), and bleeding on probing (%). All patients received basic oral care instructions from dentists. The oral health condition was generally poor in the participants and there were 24 patients (44.4%) who had severe PPD. Despite the intervention of basic oral care, the periodontal characteristics did not improve during the study period; initial FMD and follow-up FMD did not significantly differ (4.38 ± 2.74% versus 4.56 ± 2.51%, <i>P</i> = 0.562). However, the follow-up FMD was significantly lower in patients with severe PPD (≥ 6.0 mm, <i>n</i> = 24) than in patients without severe PPD (≤ 5.0 mm, <i>n</i> = 30) (FMD: 3.58 ± 1.91% versus 5.37 ± 2.67%, <i>P</i> = 0.007). FMD tended to be worse in patients with severe PPD than in patients without severe PPD (ΔFMD: -0.55 ± 2.12 versus 0.81 ± 2.77 %, <i>P</i> = 0.055). In conclusion, during the use of basic oral care, endothelial function improved in patients without severe PPD, while it worsened in patients with severe PPD.</p>\u0000<p></p>","PeriodicalId":13711,"journal":{"name":"International heart journal","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141187984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International heart journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1